SunCoast Blood Bank
1760 Mound St
Sarasota FL 34236
Mission

SunCoast Blood Bank provides a reliable supply of quality blood products and services to hospitals and health centers in need.

Leadership
CEO/Executive Director Mr. Scott M. Bush
Board Chair Mrs Kathleen Hargreaves
Board Chair Affiliation Kerkering Barberio
General Info
Organization DBA
DBA
Suncoast Communities Blood Bank
SCBB
DBA SunCoast Blood Bank
Supported Organization
Former Names
Sarasota Community Blood Bank
Suncoast Communities Blood Bank
Lower West Coast Blood Bank
Tax Exempt Status Public Supported Charity
Incorporation Year 1969
Awarded competitive grant from Community Foundation in the last 5 years? Yes
State Charitable Solicitations Permit Yes May 2016
State Registration Yes 0
IRS Letter of Determination
View
Financial Summary
 
 
Projected Revenue $13,739,428.00
Projected Expenses $13,660,758.00
Impact Statement

  •  On June 29, 2016SunCoast Blood Bank produced  the first pathogen reduced platelet units in the continental US. This follows Cerus’ FDA approvals received for the INTERCEPT Blood System for platelets and plasma in December 2014. New pathogens can emerge at any time, and this system is a first line of defense to prevent them from being transfused into compromised patients.  A blood bank must stay a step ahead of any potential health crises and be prepared to deal with them. A prime example is the Zika outbreak that is now threatening the United States and specifically, Florida. As of the date this is being written 45 cases have been diagnosed across the state of Florida. On March 1, 2016, Puerto Rico had to suspend all blood collections due to the severity of the outbreak on that island. As a result Puerto Rico has reached out to SunCoast to help supply blood products, including pathogen reduced platelets. Because SunCoast has this technology, other blood centers in at- risk states are reaching out to SunCoast to  provide them with pathogen reduced products.

    The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. The nucleic acid targeting mechanism of action of the INTERCEPT treatment is designed to inactivate established transfusion threats, such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as Chikungunya, malaria and dengue.
  • In July, 2016, SunCoast was able to replace its 30 year-old blood irradiator with a state-of-the-art unit. Thanks to community support, SunCoast was able to raise $349,000 to replace its old technology, which had essentially been rendered obsolete.

         The new irradiator has the ability to process more units in a single          cycle. It can also aliquot enough product for a newborn transfusion          without wasting the entire unit of blood. The typical amount of                blood aninfant receives in a transfusion is 1 tablespoon.                            Previously SunCoast's equipment did not allow for this, and the                rest of a good unit of blood was disposed of. In addition the new             technology is much safer because it does not have a cesium                      element. The old unit was under the supervision of Homeland                   Security, due to the possibility of cesium being used to construct a          dirty bomb.

  • SunCoast Blood Bank was proud to be named Healthcare Organization of the Year by the Sarasota Chamber of Commerce.
  • Superior fiscal management is key to running a blood bank.  Many in Florida have not survived and have been taken over.  A community blood bank run by a local board and local management is a treasure. Our last audit revealed that 92 cents of every dollar was used to fulfill our mission. 
 

Goals

Blood Bank Control System

SunCoast must raise funds over the next year to replace a major software program. The software SunCoast Blood Bank currently uses to track all steps from the time the donor presents, through manufacturing, storage and distribution to hospitals must be replaced in 2017 with a vastly improved and FDA mandated system. The Blood Bank Control System (BBCS) will provide SunCoast Blood Bank with secure, efficient, electronic blood bank software to support its operations and data management.  It will allow SunCoast to move to a more paperless system and will store all information about every blood product collected. This allows SunCoast to quickly recall or market withdraw any products as well as investigate changes in the medical profile of a donor or patient, even years later. This is an encrypted system that will protect vital patient and donor information meeting all HIPAA regulations.

As part of its strategic plan, in 2014 Suncoast affiliated with Blood Centers of America (BCA). BCA is a member-owned organization comprised of 54 independent community blood centers geographically dispersed throughout North America and Canada. The members of BCA represent the largest percentage of blood supply, providing over 37% of the U.S. blood products. BCA offers SunCoast significant benefits through group purchasing, which is the co-ops most established value program. BCA delivers savings by negotiating supply agreements with over 60 suppliers of critical products and services. As a result this will enable SunCoast to significantly reduce the cost of this purchase from $700,000 to $310,514.

 
Anemia Clinic
Although it may seem counterproductive to our mission, for several years, SunCoast has worked with local hospitals to reduce the number of unnecessary transfusions.  A transfusion is essentially a liquid transplant, and carries all the risks of a foreign element being introduced into the human body. 
 
A key to achieving such optimal surgery-related patient-centered blood management is a formal preoperative anemia management program. This fiscal year, SunCoast will put into motion, the establishment of an anemia clinic. The clinic will identify patients who are at risk for transfusion and will implement a preoperative management plan aimed at reducing or eliminating the presence/or risk of anemia and the need for allogenic transfusion. Thus reducing the inherent risks, blood inventory pressure and the cost associated with transfusion.
 
Development Program
With the help of the Board of Trustees, SunCoast continues to grow it's development program.  The Fundraising Toolkit workshop offered by the Community Foundation last year provided the board with the guidance it needed to understand the importance of a robust development program.  For the first time, the board formed a development committee and individual members committed to being responsible for raising a minimum amount to maintain their seat on the board.  As new board members are recruited, the expectation for their participation in fundraising is clearly stated.  As the board transitions from involvement in the day-to-day operation of the blood bank, they are becoming increasingly more aware of the impact development has on the bottom line.  Thus, more are stepping forward to help identify prospects in the community and open doors to which staff does not have access.
Needs Statement
  1. SunCoast continues reviewing its physical plant and assessing its brick and mortar needs.  Although the number of unnecessary blood transfusions has dropped significantly, as our population ages, the need for blood products is only going to increase. Although the instances of unnecessary transfusions has dropped significantly  Also with the addition and expansion of programs at Sarasota Memorial Hospital, including the trauma center, and potentially a cancer treatment center SunCoast must stay abreast of the community needs for blood products and the ability to house all of its operations. 
  2. As mentioned above, with blood usage down due to programs implemented by the blood bank in the best interest of the patients it serves, development is playing a greater  role in the fiscal health of the organization. As board members roll off, the organization is seeking new members who have a passion for the mission with the understanding that they must help lead the way in fundraising.
  3. As the fleet of bloodmobile ages, it is going to become necessary to replace some of the vehicles.  Some went in to commission in 1984 and repairs have become very costly.  Bloodmobiles are the workhorses of our industry and very necessary to make the process of donating as convenient as possible.
  4. SunCoast needs to establish a rare donor bank and recruit more ethnic donors.  Transfusions from similar ethnic backgrounds have better patient outcomes.  There are times when the blood bank must search the country for a specific match, thus delaying treatment for the patient.  The blood bank has the ability to store rare blood products up to 10 years in some cases.  
  5. The need to update technology is constant and expensive.  Blood banks are considered a pharmaceutical manufacturer and are highly regulated by the FDA. The FDA mandates certain upgrades and processes and the blood bank must keep up with their requirements. Therefore, once again, development is playing a greater role in the ability the purchase new technology that often exceeds our ability to pay. 
Background Statement
For 67 years, SunCoast Blood Bank (SCBB), has been the sole provider of safe and reliable blood products and services to communities in Southwest Florida. SunCoast also provides transfusion services at several local hospitals. The most common need arises from cancer patients, trauma patients, and surgical patients.  The most vulnerable patients are newborns in crisis needing blood or platelets. SCBB provides a wide range of blood services and medically-ordered therapeutic blood procedures to outpatients and inpatients throughout the region.  SunCoast Blood Bank provides 24/7 care 365 day of the year.
 
SCBB needs an average of 150 units of blood a day to meet the needs of our local hospitals and healthcare facilities. Meeting that requirement is becoming more challenging.  Less than 5% of the United States population donates blood.  Many of our most loyal blood donors, members of the “greatest generation” are no longer able to give. At the same time, the FDA is enforcing tougher safety standards disqualifying a large population of younger potential donors.
 
SunCoast Blood Bank operates five donor centers and conducts over 1,300 mobile blood drives a year. Blood drives are held at schools, businesses, community centers and places of worship seven days a week and account for 60% of all blood collection.
Areas Served
Areas Served
Area
FL- Charlotte
FL- DeSoto
FL- Manatee
FL- Sarasota
Service Categories
Primary Org Type Health Care
Secondary Org Type Health Care
Tertiary Org Type
Keywords
Blood, blood bank, saving lives, cancer treatment, transfusion services
Statement from the Board Chair/Board President

I am proud to help forward the mission of SunCoast Blood Bank, to provide a reliable supply of quality blood products and services to hospitals and health centers in need. We have faced the challenges of today’s economy, and we have thrived.  Thanks to the support of local foundations, businesses, media, civic organizations, individual financial donors, and most of all, our loyal blood donors, SunCoast is stronger than ever. Thanks to the generosity of our community, a new bloodmobile recently hit the streets, allowing SunCoast to host more than 200 additional blood drives.  We have streamlined our operations even further, with new facilities to serve as a staging hub for all of our mobile operations.  When I see Bayflite 2 in the air, I know it can't lift off the ground without the universal donor type O negative blood on board, which is my blood type.  That makes me proud to be a donor and to know that I might be saving someone's life as they are airlifted to a trauma center.  It is a privilege to serve our community and contribute to its well-being.

Kathleen Hargreaves, President
Statement from the CEO/Executive Director

SunCoast Blood Bank (SCBB) was founded in 1949 as the Lower West Coast Blood Bank. Our tagline "Live here. Give here. Stays here.," embodies our purpose. Although the name has changed, our mission to remain a local, independent blood center, providing quality blood products to community hospitals, remains strong. Not only has SCBB prevailed in the unprecedented number of blood bank consolidations in the industry, it has flourished. 

 
SCBB has become a model for independent non-profit blood centers around the country. It has established itself as an industry leader by utilizing patient blood management software (PBM). PBM tracks each individual unit of blood from the time of collection, through testing, matching and actual patient transfusion. This provides comprehensive safety assurance. PBM also allows SCBB and the hospitals it serves to reduce the cost of healthcare while improving patient care.
 
I am proud to report that soon we became the first blood bank in the country to implement the INTERCEPT pathogen reduction technology. Emerging "bugs" such as dengue and Chikungunya can be completely removed from platelets via this technology. This is significant because dengue has become prevalent in Florida and Texas. Of the 3,900 lab confirmed cases of Chikungunya, 11 were in the US, and all 11 were in Florida. If these bugs became an epidemic in the region, it would force the cessation of blood collections, mandating that all blood products be imported, at a tremendous expense to the cost of healthcare.As the Zika virus continues to proliferate in the state of Florida, this technology will prove to be a critical resource for our community, and possibly others blood banks that do not yet have the technology.
 
With excellent management, superior technology and dedicated staff, another key to our success is a strong local presence. Unlike other mega blood centers, our structure is totally community based. As a CEO living in the community we serve, with a local board, I am able to move quickly and efficiently to serve the needs of the hospitals and health care providers we work with.

SCBB is grateful for the tremendous support it receives from our community. Our blood donors and our financial donors are the backbone of our organization. We strive each day to be the best, because lives depend on it.
 
Scott Bush, CEO 
Programs
Description

A collaboration with Sarasota Memorial Hospital and Florida Cancer Specialists & Research Institute has enabled SunCoast Blood Bank to participate in groundbreaking cellular therapy (MNC) for patients undergoing ovarian and prostate cancer treatments.

With the ovarian cancer therapy still in the clinical study phase, the prostate cancer program is FDA approved and currently active in many centers across the US.

MNC is an alternative treatment for stage-four prostate cancer patients which utilizes an individual’s own white blood cells to boost his own immune system. The therapy requires the extraction of dendritic cells which are sent to a lab for processing. These are then returned to be re-infused into the patient in the form of a vaccine designed to seek and attack prostate cancer cells. By stimulating the natural ability of immune cells already in the patient’s body, this therapy helps fight advanced prostate cancer.
Budget $180,000
Category Medical Research, General/Other Cancer Research
Program Linked to Organizational Strategy Yes
Population Served Adults Males Adults
Short Term Success

MNC therapy is a rapidly growing and active field as more and more laboratories are finding ways to treat cancer.  Given the time required by each procedure and the regimen of treatments ordered for each patient, it is imperative that patients have access to a local provider of this service. Local patients undergoing prostate cancer treatment that require the MNC procedure no longer have to leave the comfort of their own community to receive care in larger centers.  With the expansion of our services to implement our own therapy center, local patients will have the option to be treated locally by an approved, regulated and suitably prepared institution.

Long Term Success

Only licensed and properly equipped institutions can perform this procedure and SunCoast Blood Bank has the expertise and trained staff to offer this service to our community. MNC therapy is gaining momentum as a plan of treatment as more and more laboratories are finding ways to treat cancer.

Program Success Monitoring

Patients currently undergoing MNC therapy for stage-four prostate cancer are under the supervision of their local oncologist. SCBB works closely with their medical providers during their treatment.

In a clinical trial that supported FDA approval, more men treated with MNC lived longer than men not using same procedure. More men in the same treatment group were alive 3 years after the start of the study than men not treated with the vaccine. The vaccine reduced the risk of death by 22.5% for patients in the treatment group and only 1.5% of men discontinued treatment due to side effects.

Program Success Examples

MNC is an immunotherapy of autologous dendritic cells re-infused into the patient consisting of prostatic acid phosphatase (PAP) linked to granulocyte-macrophage colony-stimulating factor. Sequential phase I and phase II trials were performed to determine the safety and efficacy of the vaccine and to assess its capacity to break. Reports from vaccine manufacturer shows that patients tolerated treatment well. Fever, the most common adverse event, occurred after 15 infusions (14.7%). All patients developed immune responses to the fusion protein used to prepare the vaccine, and 38% developed immune responses to PAP. Three patients had a more than 50% decline in prostate-specific antigen (PSA) level, and another three patients had 25% to 49% decreases in PSA. The time to disease progression correlated with development of an immune response to PAP and with the dose of dendritic cells received immune tolerance to the normal tissue antigen PAP.

Description
The Generation Give Scholarship Program was established in 2006. Studies show that students who begin donating in high school are likely to become life-long donors. The Generation Give program was established to motivate students to donate, thus beginning a life-long service to their community. As the economy began to struggle, the need for financial assistance to obtain the dream of a college education became greater, making SCBB's scholarship program a win-win situation. Students experience first-hand the opportunity to commit a life-saving act, and in turn they are eligible to receive a partial scholarship towards college tuition.
 
To be eligible, a student must donate blood or platelets three times during their senior year or demonstrate support of the SCBB mission by volunteering at least 26 hours their senior year. This can be done by promoting school blood drives, volunteering for SCBB or acting as a "Blood Buddy" during their graduation year. (Blood Buddy is a student volunteer who helps out on the days of the drive). Upon successfully completing these requirements, the student may apply for a scholarship, which if awarded, is paid directly to the college or university.
Budget $20,000
Category Education, General/Other Education, General/Other
Program Linked to Organizational Strategy Yes
Population Served Other Named Groups Other Named Groups Other Named Groups
Short Term Success

Students now account for 25% of total blood donated in our community.  As we face an on-going decrease in the population of adult donors, it is imperative that we continue reaching out to our youth to emphasize the importance of blood donation and the impact they are making in other people's lives by becoming a blood donor.

Long Term Success

National studies show that adolescents who donate blood at least three times are most likely to become life-long blood donors.  Cultivating the next generation of blood donors is one step closer to assure that demand for blood will not exceed supply - an ongoing threat faced by all blood banks.

Program Success Monitoring

Community volunteers and SCBB staff comprise a committee to establish guidelines and to review each scholarship application. As part of the application process, students are asked to evaluate several key areas that helps SCBB determine what best motivates students to become blood donors.

Program Success Examples

SCBB has distributed over $124,000 in college scholarships since the creation of the program. In 2014, 54 high school seniors were awarded more than $24,000 in scholarships. SCBB maintains an extensive database that allows us to track donors. The data indicates that many of our young adult donors, began giving blood in high school.

Description

My Blood, Your Blood (MBYB) program was designed by a team of physicians and educators as a low-prep time, turnkey package to be used either in the classroom or the home-school environment. Through sophisticated animation and microscopy, the program captures the imagination of students of all ages and helps foster an interest in science. The program also emphasizes the value of community service through blood donation and the importance of a healthy lifestyle.

Budget $1,000
Category Education, General/Other
Program Linked to Organizational Strategy Yes
Population Served Children Only (5 - 14 years)
Short Term Success

MBYB contributes to the science curriculum at a time when scores in science are falling. The program contains information useful to students taking the state's FCAT. The support materials given to the student also encourages dialogue with the family about what they have learned about blood and the importance of blood donation.

Long Term Success

Exposing children to the vital nature of blood as part of the body's physiology, plants the seed that blood is a product that is critical to our very survival. The program teaches the science of blood including its role in transporting nutrients, regulating our internal environment and protecting us from disease. The program introduces the importance of blood donation as a life-saving contribution that can begin at the age of 16. This sets the stage for students to participate in blood drives once they are old enough.

Program Success Monitoring

Upon completion of the program, teachers are asked to complete an evaluation. Results of those evaluations indicate that MBYB program is beneficial to the students and that the students enjoy the educational video, materials and pencils.  Teachers also find that this program is relevant with the class’s current curriculum.  The program is consistently rated as well-organized, well-presented, age appropriate, and “kid friendly”. 

Suggestions for improvement are predominately for more hands-on activities (hands-on activities are available for presenters to use). A pilot high school home school program was initiated for the 2011-2012 school year with a team approach of the program presenter and a SCBB registered nurse. All the students elected to have their blood typed.
Program Success Examples

Comments from surveys regarding plans for follow up included a microscope activity, using blood cell slides, quizzes and activities provided in the packets.  Requests that the program be executed again appeared on many surveys.  Follow up with the 2011-2012 on-going pilot for high school home schooled students: Students are recruiting donors as part of their community service hours, those who are old enough donate, and the science teacher incorporates more information about blood and the circulatory system before each blood drive. 

Description

SunCoast has taken steps to make the blood supply even safer by being the first blood bank in the country to acquire the INTERCEPT Blood System for platelets and plasma. This revolutionary technology significantly reduces the risk of transfusion-transmitted pathogens such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as Chikungunya, malaria, and dengue. Platelets are vital in the treatment of cancer patients, who are also the most vulnerable to fatal complications caused by pathogens. Platelets contaminated with bacteria remain one of the highest causes of transfusion-related mortality, and Pathogen Reduction will  dramatically improve patient outcomes in our community.

Cerus created a molecule called amotosalen which is filtered into the platelets and binds itself to DNA and RNA. The unit of platelets is then placed under a UV light which envelopes the pathogens which are then filtered out.

Budget $50,000
Category Health Care, General/Other Blood Banking
Program Linked to Organizational Strategy Yes
Population Served Adults Children and Youth (0 - 19 years) Aging, Elderly, Senior Citizens
Short Term Success
Because platelets contaminated with bacteria remain one of the highest causes of transfusion-related mortality, and Pathogen Reduction will dramatically reduce this possibility and improve patient outcomes in our community. An added benefit of the technology is that platelets can be released earlier after testing. Because they must be stored at room temperature, platelets are only good for five days. INTERCEPT can increase platelet effective shelf life by as much as half a day. This is significant since less than one percent of the population donates 100 percent of this vital blood product.
 
Emerging "bugs" such as dengue and Chikungunya can be completely removed from platelets via this technology. This is significant because dengue has become prevalent in Florida and Texas. Of the 3,900 lab confirmed cases of Chikungunya, 11 were in the US, and all 11 were in Florida. If these bugs became an epidemic in the region, it would force the cessation of blood collections.
Long Term Success Currently the technology is only approved for platelets.  The blood banking industry is hopeful that the FDA will approve the technology for red cells.  This would enhance the safety of the blood supply on an entirely new level.
Program Success Monitoring The community should see a significant reduction in the number of bacteria-related complications.
Program Success Examples

The most relevant example is the use of the technology to combat the Ebola epidemic. Cerus was part of the team that went to West Africa as part of the Gates Foundation initiative to combat Ebola. Their INTERCEPT Blood System, was used to manufacture convalescent plasma to treat patients. The same technology was used for Ebola patients transferred to the United States for treatment.

Comments
Program Comments by Organization
The biggest challenge is containing the cost of collecting, testing, storing and transfusing blood products.  Hospitals are under pressure to keep the cost of healthcare in line and this filters down to the blood bank.  SunCoast has one of the leanest operations in the country due to its efficient operations and skilled staff. Most of the blood bankassociated technology is mandated by the FDA and is constantly evolving, improving and emerging.  SunCoast must rely on voluntary financial contributions to cover the cost of the technology required to keep the blood supply safe and available.
 
Another challenge continues to be the shrinking donor pool.  In order to attract and retain donors, SCBB recently launched an online donor rewards program, where donors can redeem points awarded from donating blood or platelets. Points can be redeemed for gift cards and SCBB merchandise. SCBB has also increased its visibility by partnering with local media outlets, including ABC 7, WUSF, WCTQ, WSRZ. 92.1 The Coast, The Bradenton Herald and Sarasota Herald Tribune. 
 
Scott Bush, CEO 
Program Comments by Foundation
CEO/Executive Director
CEO/Executive Director Mr. Scott M. Bush
CEO Term Start Aug 2011
CEO/Executive Director Email sbush@scbb.org
Experience

Scott has over 20 years of experience in blood banking and joined SCBB in 2005 as Director of Donor Services and Recruitment. Most recently, Bush served as Chief Operating Officer, overseeing SCBB’s expansion into Manatee and Charlotte counties.  During his employment at SCBB, Bush was recognized as a Top 40 Under 40 by the Gulf Coast Business Review in 2009 and also was awarded Executive of the Year by the Florida Association of Blood Banks in 2008. Prior to joining SCBB, Bush worked with the American Red Cross for 15 years overseeing various departments within their biomedical service operation.  Bush also served in the United States Naval Reserve where he received the Navy Medal of Achievement.
Scott is a graduate of Ohio Dominican University and earned his masters degree in non-profit management from University of Central Florida. He resides in Parrish.

Former CEOs/Executive Directors
NameTerm
Mr. Kevin Lindberg Dec 2010 - Aug 2011
Dr. Mark J. Magenheim May 2003 - Dec 2010
Senior Staff
NameTitle
Mr. Christopher Ebert Information Technology Director
Mrs. Chris Flood Director of Laboratory Services
Mrs. Ginger Fudge Director of Recruitment
Mrs. Jayne Giroux Director of Community Development
John Hall Director of Donor Services
Mr. Robert Harper Director of Quality Assurance
Mrs. Karen Hoder Accounting Supervisor
Ms. Laura Williams Dircetor of Human Resources
Staff & Volunteer Statistics
Full Time Staff 91
Part Time Staff 38
Staff Retention Rate % 73
Professional Development Yes
Contractors 0
Volunteers 65
Management Reports to Board Yes
CEO/Executive Director Formal Evaluation Yes
Senior Management Formal Evaluation Yes
Non-Management Formal Evaluation Yes
Collaborations
  • Alliance for Community Transfusion Services
  • Blood Centers of America
  • Florida Cancer Specialists & Research Institute
  • Sarasota Memorial Hospital
  • American Heart Association
  • Animal Rescue Coalition
  • Manatee Memorial Hospital Foundation
  • Wildlife Rescue
  • Healthsouth Rehabilitation Hospital
Affiliations
AffiliationYear
2000
2000
2000
External Assessments and Accreditations
Assessment/AccreditationYear
State of Florida Clinical Laboratory License2013
AABB Transfusion Activities Accreditation2015
Awards & Recognition
Award/RecognitionOrganizationYear
Dorothy M. Hansen Admnistrator of the YearFlorida Association of Blood Banks2011
Most Creative Donor Center EventFlorida Association of Blood Banks2013
Terumo BCT Award of Excellence in Donor RecruitmentAmerica's Blood Centers2013
The Most Creative Donor Center AwardFlorida Association of Blood Banks2012
Board Memeber of the Year - Maggie VeenemanFlorida Association of Blood Banks2012
Media of the Year Award - WSRZ 107.9America's Blood Centers2012
High School Achievement Award for a Mid-Size School - Sarasota Military AcademyFlorida Association of Blood Banks2012
Overall Most Productive Blood Drive - WSRZ 107.9Florida Association of Blood Banks2013
Media Partnership of the Year- WWSB ABC 7Florida Association of Blood Banks2013
Dorothy C Smith R.N. Award - John HorneFlorida Association of Blood Banks2014
Hospital Donor Group Achievement Award - Fawcett Memorial HospitalFlorida Association of Blood Banks2014
Hospital Partnership Award - Sarasota Memorial HospitalFlorida Association of Blood Banks2014
Donor Chairperson of the Year - Leslie CollierFlorida Association of Blood Banks2014
High School Achievement Award for Highest Participation of Mid-Sized Schools - Desoto High SchoolFlorida Association of Blood Banks2014
Terumo BCT Award of Excellence in Donor RecruitmentAmerica's Blood Centers2015
ITxM Award for Excellence in Technical OperationsAmerica's Blood Centers2015
Outstanding Humanitarian Service AwardAmerica's Blood Centers2015
Board Member of the Year - Mary Ann LeglerFlorida Association of Blood Banks2015
Most Creative Donor Center AwardFlorida Association of Blood Banks2015
Media Partnership Service AwardFlorida Association of Blood Banks2015
Innovation AwardFlorida Association of Blood Banks2015
Hopsital Medical Professional Advocate of the Year AwardFlorida Association of Blood Banks2015
Dorothy M. Hansen Executive of the Year Award - Jason CarneyFlorida Association of Blood Banks2015
High School Achievement Award for Highest Participation of Large-Sized Schools - Manatee High SchoolFlorida Association of Blood Banks2015
High School Achievement Award for Most Donations of Large-Sized Schools - Manatee High School2015
Finalist - Champions of Healthcare AwardsManatee Chamber of Commerce2015
Finalist - Healtcare/Wellness Organization of the Year Small Business AwardsSarasota Chamber of Commerce2015
ITxM Award for Excellence in Technical OperationsAmerica's Blood Centers2016
Terumo BCT Award of ExcellenceAmerica's Blood Centers2016
Healthcare Organization of the YearSarasota Chamber of Commerce2015
Risk Management Provisions
Automobile Insurance and Umbrella or Excess Insurance
Accident and Injury Coverage
Builders Risk
Commercial General Liability
Computer Equipment and Software
Disability Insurance
Employee Dishonesty
Fiduciary Liability
Flood
General Property Coverage
Life Insurance
Medical Health Insurance
Professional Liability
Workers Compensation and Employers' Liability
Government Licenses
Organization Licensed by the Government Yes
Plans
Fundraising Plan Yes
Communication Plan Yes
Strategic Plan No
Strategic Plan Years 2
Strategic Plan Adopted Sept 2013
Management Succession Plan No
Continuity of Operations Plan No
Policies
Nondiscrimination Policy Yes
Whistle Blower Policy Yes
Document Destruction Policy Yes
Directors and Officers Insurance Policy No
Policies and Procedures Yes
Comments
Management Comments by Organization
SCBB is fortunate to have a staff of dedicated employees committed to our mission.  The senior staff each oversee a pivotal portion of our operation and are experts in their fields.
 
The constant struggle of a blood bank is managing costs and recruiting new donors.  Because competitors sizable incentives to their donors, SunCoast  has made it a goal to appeal to the donors sense of duty.
 It has done so through marketing campaigns, social media, and one-on-one interaction with donors. The implementation of a donor rewards store has cut down significantly on the cost of incentives. Donors accumulate points each time they give a donation and can retrieve items such as gift cards, books etc. from the store. Many of these items are donated. In addition, the donor has the option to forfeit their points and contribute to the high school scholarship program. Many donors elect this option. This tells us that our efforts to appeal to donors sense of pride in donating is becoming more and more successful.
Scott Bush, CEO 
Management Comments by Foundation
Board Chair
Board Chair Mrs Kathleen Hargreaves
Company Affiliation Kerkering Barberio
Board Term Nov 2014 to Oct 2016
Board Chair Email khargreaves@kbgrp.com
Board Members
Board Members
NameAffiliation
Mr. Martin Black Thomas Ranch Land Partners
Steve Branham Retired
Mr. William Dooley Dooley Mack
Mr. James Gabbert Gabbert Investment Group
Mr. Chris Gray Community Volunteer
Mrs. Kathleen Hargreaves Kerkering Barberio
Mr. Ben Hatcher Capstan Financial Group
Mrs. Mary Ann Legler Manatee County School Board
Mr. Alan Maio Kimley-Horn & Associates
Mr. Jeffery Reynolds Retired
Mr. Craig Tuley SunTrust
Mrs. Margaret Veeneman Sarasota Financial Partners
Student serving on the board through Community Youth Development? No
Constituency Includes Client Representation No
Board Ethnicity
African American/Black 0
Asian American/Pacific Islander 0
Caucasian 12
Hispanic/Latino 0
Native American/American Indian 0
Other 0 0
Board Gender
Male 9
Female 3
Unspecified 0
Governance
Board Term Lengths 3
Board Term Limits 3
Board Orientation Yes
Number of Full Board Meetings Annually 5
Board Meeting Attendance % 62
Board Self-Evaluation No
Written Board Selection Criteria No
Board Conflict of Interest Policy Yes
% of Board Making Monetary Contributions 92
% of Board Making In-Kind Contributions 20
Standing Committees
Audit
Board Development / Board Orientation
Board Governance
Finance
Human Resources / Personnel
Strategic Planning / Strategic Direction
Development / Fund Development / Fund Raising / Grant Writing / Major Gifts
Comments
Governance Comments by Organization
Unlike large blood bank conglomerates, the SCBB Board of Directors plays a pivotal role in the direction of the organization.  Blood banking is a highly regulated, technical institution and it takes more time than is traditional for board members to feel comfortable in their decision making role.  They must understand the technology and the operational needs in order to make informed decisions about capital items as well as policies.  For this reason, term limits are longer than you might see with other nonprofits. 
 
Greater emphasis is being placed on fund development and the role of the board. Therefore, SCBB is seeking potential board members with the willingness and aptitude to immerse themselves in this process. 
 
Scott Bush, CEO 
Governance Comments by Foundation
Fiscal Year Projections
Fiscal Year Begins 2015
Fiscal Year Ends 2016
Projected Revenue $13,739,428.00
Projected Expenses $13,660,758.00
Endowment Value
Endowment Spending Policy N/A
Endowment Spending Policy %
Capital Campaign
In a Capital Campaign Yes
Campaign Purpose Purchase a Rad Source 4pi X-Ray Blood Irradiator. This instrument is vital to our mission to provide safe and reliable blood products as it eradicates antigens from blood which can cause a life-threatening reaction in transfusion patients.
Campaign Goal $327,800.00
Campaign Dates Oct 2014 to Sept 2015
Amount Raised To Date 204065 as of Feb 2015
Anticipate Campaign within 5 years? Yes
Historical Financial Review
Revenue SourcesHelpThe financial analysis involves a comparison of the IRS Form 990 and the audit report (when available) and revenue sources may not sum to total based on reconciliation differences. Revenue from foundations and corporations may include individual contributions when not itemized separately.
Fiscal Year201520142013
Foundation and
Corporation Contributions
$0$0$0
Government Contributions$0$0$0
Federal$0$0$0
State$0$0$0
Local$0$0$0
Unspecified$0$0$0
Individual Contributions$321,331$308,550$251,632
$0$0$0
$12,279,958$12,841,019$13,077,248
Investment Income, Net of Losses($77,314)$50,951$62,178
Membership Dues$0$0$0
Special Events$44,416$26,551$64,369
Revenue In-Kind$288,877$271,468$232,920
Other$0$25,451$32,142
Expense Allocation
Fiscal Year201520142013
Program Expense$12,030,095$12,594,549$12,354,077
Administration Expense$914,130$888,320$973,969
Fundraising Expense$162,199$75,437$111,242
Payments to Affiliates$0$0$0
Total Revenue/Total Expenses0.980.981.00
Program Expense/Total Expenses92%93%92%
Fundraising Expense/Contributed Revenue44%23%35%
Assets and Liabilities
Fiscal Year201520142013
Total Assets$8,885,068$9,210,723$9,565,096
Current Assets$4,845,258$5,200,979$6,497,405
Long-Term Liabilities$299,948$179,000$108,000
Current Liabilities$927,911$1,125,358$1,308,032
Total Net Assets$7,657,209$7,906,365$8,149,064
Top Funding Sources
Fiscal Year201520142013
Top Funding Source & Dollar AmountProcessing and Service Fees $8,098,868Processing and service fees $8,991,935Process & Service Fees $10,187,255
Second Highest Funding Source & Dollar AmountLaboratory Test Fees $2,102,696Lab Test Fees $1,978,295Lab Test Fees $2,011,229
Third Highest Funding Source & Dollar AmountExport Fees $1,292,394Export Fees $1,162,404Plasma Sales $627,670
CEO/Executive Director Compensation $150,001 - $175,000
Co-CEO/Executive Director Compensation
Tax Credits No
Solvency
Short Term Solvency
Fiscal Year201520142013
Current Ratio: Current Assets/Current Liabilities5.224.624.97
Long Term Solvency
Fiscal Year201520142013
Long-Term Liabilities/Total Assets3%2%1%
Financials Comments
Financial Comments by Organization

Blood centers are unique among not-for-profit organizations in that when operating efficiently, our operating expenses can be covered from fees charged for our products and services.  I am proud to report that SunCoast Blood Bank’s operation is extremely efficient and cost effective. In the rare event of a natural or other disaster if hospital demand were to exceed SunCoast’s current level of supply, we also maintain funds which would enable us to purchase and import blood products from other parts of country.  Our primary challenge is absorbing the costs of capital equipment.  These purchases are not luxuries.  Rather, they are necessities often mandated by the Federal Drug Administration in order for us to continue to safely collect, manufacture, store, and deliver blood components.  We allocate a significant amount of funds toward capital improvements, however, the mandated and medically advised advancements required often exceed our ability to pay.  Therefore, we rely on the generosity of foundations and individuals to help us remain operational as we strive to maintain a safe and reliable blood supply for our community. 

Scott Bush, CEO 

Financial Comments by Foundation
Financial figures taken from IRS Form 990 and audit documents.  990s and audits are reconciled for 2009 and 2010.  Total liabilities reported in 2008 audit: $776,879.  Individual contributions include foundation and corporate support, as reported on Form 990. In-kind contribution revenue includes non-cash contributions and donated services and use of facilities as reported on the IRS Form 990.  Donated services and facilities are not included in total revenue on the IRS Form 990.  Financial information for 2015 was taken solely from the audited financial statements as the Federal tax return was not available at time of review.
Nonprofit SunCoast Blood Bank
Address 1760 Mound St
Sarasota, FL 34236
Phone 941 954-1600 124

THE COMMUNITY FOUNDATION OF SARASOTA COUNTY, INC. IS A REGISTERED 501(C)(3) NON-PROFIT CORPORATION. A COPY OF THE OFFICIAL REGISTRATION AND FINANCIAL INFORMATION MAY BE OBTAINED FROM THE DIVISION OF CONSUMER SERVICES BY CALLING TOLL-FREE WITHIN THE STATE (1-800-HELP-FLA) OR FROM THE WEBSITE: WWW.FRESHFROMFLORIDA.COM. REGISTRATION DOES NOT IMPLY ENDORSEMENT, APPROVAL, OR RECOMMENDATION BY THE STATE. ONE HUNDRED PERCENT (100%) OF EACH CONTRIBUTION IS RECEIVED BY THE COMMUNITY FOUNDATION OF SARASOTA COUNTY. REGISTRATION #SC-02471.